Malden, MA, United States of America

Jefferson Puerta


 

 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Jefferson Puerta: Innovator in Microfluidic Technologies

Introduction

Jefferson Puerta is a prominent inventor based in Malden, MA, known for his significant contributions to the field of microfluidics. With a total of seven patents to his name, he has made remarkable advancements in the growth of intestinal cells and compound distribution within microfluidic devices. His work has the potential to revolutionize the study of physiological functions and disease modeling.

Latest Patents

One of Puerta's latest patents focuses on "Systems and methods for growth of intestinal cells in microfluidic devices." This invention addresses the limitations of existing intestinal cell cultures by utilizing iPSC-derived epithelium, including patient-specific cells, to enhance disease modeling for inflammatory bowel diseases. Another notable patent is related to "Compound distribution in microfluidic devices," which aims to improve the absorbency of molecules and compounds in laboratory equipment while ensuring gas transport is not hindered.

Career Highlights

Throughout his career, Puerta has worked with esteemed organizations such as Emulate, Inc. and Harvard College. His innovative approaches have garnered attention in the scientific community, particularly in the realm of organ-on-chip technologies.

Collaborations

Puerta has collaborated with notable colleagues, including Daniel Levner and S Jordan Kerns, contributing to the advancement of microfluidic research and applications.

Conclusion

Jefferson Puerta's work in microfluidics exemplifies the intersection of innovation and practical application in biomedical research. His patents not only enhance our understanding of intestinal cell behavior but also pave the way for future advancements in disease modeling and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…